Fernando Javier Barreyro

1.3k total citations
25 papers, 876 citations indexed

About

Fernando Javier Barreyro is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Fernando Javier Barreyro has authored 25 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Fernando Javier Barreyro's work include Liver Disease Diagnosis and Treatment (16 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Diet, Metabolism, and Disease (4 papers). Fernando Javier Barreyro is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Diet, Metabolism, and Disease (4 papers). Fernando Javier Barreyro collaborates with scholars based in Argentina, United States and Peru. Fernando Javier Barreyro's co-authors include Gregory J. Gores, Steven F. Bronk, Harmeet Malhi, Nathan W. Werneburg, Hajime Isomoto, Paola Finocchietto, Silvia Holod, Marı́a C. Carreras, Shogo Kobayashi and Jorge B. Aquino and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Fernando Javier Barreyro

25 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando Javier Barreyro Argentina	10	564	285	284	167	139	25	876
John Brooling United States	11	495 0.9×	362 1.3×	257 0.9×	108 0.6×	223 1.6×	15	926
Suxian Zhao China	19	630 1.1×	374 1.3×	429 1.5×	68 0.4×	168 1.2×	58	1.2k
Elena Kotsiliti United Kingdom	2	662 1.2×	339 1.2×	295 1.0×	148 0.9×	86 0.6×	2	988
Kimberly Viker United States	13	568 1.0×	192 0.7×	217 0.8×	168 1.0×	131 0.9×	18	915
Kyle L. Poulsen United States	16	457 0.8×	169 0.6×	257 0.9×	94 0.6×	90 0.6×	29	878
Andrew Dellinger United States	12	490 0.9×	168 0.6×	349 1.2×	130 0.8×	71 0.5×	27	935
Sergi Guixé‐Muntet Spain	19	606 1.1×	448 1.6×	209 0.7×	97 0.6×	197 1.4×	30	883
Charles‐Henry Gattolliat France	11	413 0.7×	153 0.5×	429 1.5×	93 0.6×	58 0.4×	12	881
Lay T. Gan Australia	4	529 0.9×	146 0.5×	170 0.6×	98 0.6×	99 0.7×	5	668
Andrea Marengo Italy	9	544 1.0×	296 1.0×	265 0.9×	69 0.4×	91 0.7×	12	892

Countries citing papers authored by Fernando Javier Barreyro

Since Specialization

Citations

This map shows the geographic impact of Fernando Javier Barreyro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Javier Barreyro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Javier Barreyro more than expected).

Fields of papers citing papers by Fernando Javier Barreyro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Javier Barreyro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Javier Barreyro. The network helps show where Fernando Javier Barreyro may publish in the future.

Co-authorship network of co-authors of Fernando Javier Barreyro

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Javier Barreyro. A scholar is included among the top collaborators of Fernando Javier Barreyro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Javier Barreyro. Fernando Javier Barreyro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zapata, Pedro Darío, et al.. (2024). Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease. Annals of Hepatology. 29(6). 101541–101541. 1 indexed citations

Zapata, Pedro Darío, et al.. (2024). The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease. PLoS ONE. 19(9). e0310361–e0310361. 6 indexed citations

Barreyro, Fernando Javier, et al.. (2024). Worldwide Increasing Prevalence of Non-alcoholic Steatohepatitis as an Indication of Liver Transplantation: Epidemiological View and Implications. Current Hepatology Reports. 23(1). 193–203. 2 indexed citations

Barreyro, Fernando Javier, et al.. (2023). Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia. Helicobacter. 28(5). e13002–e13002. 4 indexed citations

Barreyro, Fernando Javier, et al.. (2022). S1234 Helicobacter pylori Infection and Cag-A Strain Are Associated With NAFLD Severity. The American Journal of Gastroenterology. 117(10S). e892–e893. 1 indexed citations

Fassio, E, et al.. (2022). Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?. World Journal of Hepatology. 14(2). 354–371. 6 indexed citations

Sordá, Juan, et al.. (2021). Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up. Alimentary Pharmacology & Therapeutics. 54(9). 1202–1212. 17 indexed citations

Balderramo, Domingo, Enrique Carrera, Fernando Javier Barreyro, et al.. (2018). PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings. Hepatitis Monthly. In Press(In Press). 2 indexed citations

Ridruejo, Ezequiel, Manuel Mendizábal, Federico Piñero, et al.. (2018). Safety and effectiveness comparing generic and original sofosbuvir-based treatment regimens in patients with hepatitis C: A prospective multicenter study from Argentina. Journal of Hepatology. 68. S280–S280. 1 indexed citations

10.

Terg, Rubén, Paola Casciato, Mariano Cartier, et al.. (2014). Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study. Journal of Hepatology. 62(5). 1056–1060. 85 indexed citations

11.

Barreyro, Fernando Javier, Silvia Holod, Paola Finocchietto, et al.. (2014). The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis. Liver International. 35(3). 953–966. 233 indexed citations

12.

Finocchietto, Paola, Silvia Holod, Fernando Javier Barreyro, et al.. (2011). Defective Leptin–AMP-Dependent Kinase Pathway Induces Nitric Oxide Release and Contributes to Mitochondrial Dysfunction and Obesity in ob/ob Mice. Antioxidants and Redox Signaling. 15(9). 2395–2406. 22 indexed citations

13.

Hwang, Hui Jer, Edgardo Smecuol, Horacio Vázquez, et al.. (2010). M1267 Increased Intestinal Permeability (IP) in Cirrhosis is Associated to the Severity of the Liver Disease and a Higher Mortality. Gastroenterology. 138(5). S–367. 2 indexed citations

14.

Mott, Justin L., Yuko Akazawa, Fernando Javier Barreyro, et al.. (2010). Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. Hepatology Research. 40(7). 701–710. 7 indexed citations

15.

Barreyro, Fernando Javier, Silvia Holod, Paola Finocchietto, et al.. (2010). 779 PF-03491390 PAN-CASPASE INHIBITOR DECREASES LIVER INJURY AND FIBROSIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH). Journal of Hepatology. 52. S303–S303. 2 indexed citations

16.

Kahraman, Alişan, Fernando Javier Barreyro, Steven F. Bronk, et al.. (2008). TRAIL mediates liver injury by the innate immune system in the bile duct–ligated mouse†. Hepatology. 47(4). 1317–1330. 72 indexed citations

17.

Finocchietto, Paola, Fernando Javier Barreyro, Silvia Holod, et al.. (2008). Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome. PLoS ONE. 3(3). e1749–e1749. 32 indexed citations

18.

Kahraman, Alişan, Justin L. Mott, Steven F. Bronk, et al.. (2008). Overexpression of Mcl-1 Attenuates Liver Injury and Fibrosis in the Bile Duct–Ligated Mouse. Digestive Diseases and Sciences. 54(9). 1908–1917. 14 indexed citations

19.

Barreyro, Fernando Javier, Shogo Kobayashi, Steven F. Bronk, et al.. (2007). Transcriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis. Journal of Biological Chemistry. 282(37). 27141–27154. 166 indexed citations

20.

Malhi, Harmeet, Fernando Javier Barreyro, Hajime Isomoto, Steven F. Bronk, & Gregory J. Gores. (2007). Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut. 56(8). 1124–1131. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact